LFMD · NASDAQ · Medical - Healthcare Information Services

LifeMD (LFMD)

Connecting patients to virtual primary and specialty care with pharmacy access.

$3.19
vs last close−0.11 (−3.48%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue394544515364666260475047
Cost of revenue555559977985
Gross profit344040464855575553384342
384246525254555655395149
Research & development122232333200
333639454546464746354542
Selling & marketing20202426272629292903028
General & administrative13161519182017181701514
Other expenses444556666367
Operating income−5−2−6−6−413−1−2−1−9−7
−1−10−1−1−1−1−1−1000
Interest income000000000000
Interest expense110111110000
Other non-operating income000000001000
Income before tax−5−3−7−7−502−2−3−1−9−7
Income tax expense000000000000
Net income from continuing operations−5−3−7−7−502−2−4−1−9−7
Discontinued operations000000000000
Net income−6−4−7−7−501−2−4−1−9−7
EPS, basic−$0.18−$0.10−$0.17−$0.17−$0.14−$0.02$0.01−$0.06−$0.10−$0.05−$0.20−$0.16
EPS, diluted−$0.18−$0.10−$0.17−$0.17−$0.14−$0.02$0.01−$0.06−$0.10−$0.05−$0.20−$0.16
Weighted average shares, basic343739414242434446474748
Weighted average shares, diluted343739414242464446474748
EBITDA−3−2−4−4−145201−7−7
Depreciation & amortization202233333220
EBIT−5−2−6−6−413−1−3−1−9−7